Slocum, Gordon & CO LLP has filed its 13F form on May 02, 2024 for Q1 2024 where it was disclosed a total value porftolio of $129 Million distributed in 131 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Merck & Co., Inc. with a value of $13.9M, Procter & Gamble CO with a value of $9.28M, Exxon Mobil Corp with a value of $8.27M, Johnson & Johnson with a value of $8.21M, and Abb Vie Inc. with a value of $7.74M.

Examining the 13F form we can see an increase of $17M in the current position value, from $112M to 129M.

Slocum, Gordon & CO LLP is based out at Newport, RI

Below you can find more details about Slocum, Gordon & CO LLP portfolio as well as his latest detailed transactions.

Portfolio value $129 Million
Healthcare: $36.7 Million
Utilities: $23.5 Million
Consumer Defensive: $19.3 Million
Energy: $17.3 Million
Communication Services: $8.05 Million
Industrials: $7.02 Million
Technology: $5.22 Million
Financial Services: $5.06 Million
Other: $6.96 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 131
  • Current Value $129 Million
  • Prior Value $112 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 02, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 4 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 32 stocks
Track This Portfolio

Track Slocum, Gordon & CO LLP Portfolio

Follow Slocum, Gordon & CO LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slocum, Gordon & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Slocum, Gordon & CO LLP with notifications on news.